(Q38212628)

31 August 2017

title

Induced pluripotent stem cells for modeling of pediatric neurological disorders (English)

1 reference

31 August 2017

6

Hoon-Chul Kang

1 reference

31 August 2017

Jiho Jang

1

1 reference

31 August 2017

Zhejiu Quan

2

1 reference

31 August 2017

Yunjin J Yum

3

1 reference

31 August 2017

Hyo Sook Song

4

1 reference

31 August 2017

Seonyeol Paek

5

1 reference

31 August 2017

publication date

25 June 2014

1 reference

31 August 2017

published in

Biotechnology Journal

1 reference

31 August 2017

volume

9

1 reference

31 August 2017

issue

7

1 reference

31 August 2017

page(s)

871-881

1 reference

Induced pluripotent stem cells (iPSCs) and neurological disease modeling: progress and promises

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Induced pluripotent stem cell lines derived from human somatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Epigenetic memory in induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Generation of mouse induced pluripotent stem cells without viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

A nonviral minicircle vector for deriving human iPS cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

A more efficient method to generate integration-free human iPS cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Dissecting direct reprogramming through integrative genomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Vitamin C enhances the generation of mouse and human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Rapamycin and other longevity-promoting compounds enhance the generation of mouse induced pluripotent stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Lithium, an anti-psychotic drug, greatly enhances the generation of induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Robust activation of the human but not mouse telomerase gene during the induction of pluripotency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Deterministic direct reprogramming of somatic cells to pluripotency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Embryonic stem cell lines derived from human blastocysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Breaking the code of DNA binding specificity of TAL-type III effectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

A transcription activator-like effector toolbox for genome engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

RNA-guided human genome engineering via Cas9

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Modeling human disease with pluripotent stem cells: from genome association to function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Immunogenicity of induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Induced pluripotent stem cell-derived neural cells survive and mature in the nonhuman primate brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Developing rods transplanted into the degenerating retina of Crx-knockout mice exhibit neural activity similar to native photoreceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Embryonic stem cell trials for macular degeneration: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Functional maturation of hPSC-derived forebrain interneurons requires an extended timeline and mimics human neural development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

LINE-1 retrotransposons: mediators of somatic variation in neuronal genomes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

L1 retrotransposition in neurons is modulated by MeCP2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Microcephalin, a Gene Regulating Brain Size, Continues to Evolve Adaptively in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

iPS cells to model CDKL5-related disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Triplet Repeat Expansion Mutations: The Example of Fragile X Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

The challenge of Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Chromosome 21 and down syndrome: from genomics to pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

A human stem cell model of early Alzheimer's disease pathology in Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Genomic and functional profiling of human Down syndrome neural progenitors implicates S100B and aquaporin 4 in cell injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Disease-specific induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Clinical and genetic aspects of Angelman syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader–Willi syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Induced Pluripotent Stem Cells Can Be Used to Model the Genomic Imprinting Disorder Prader-Willi Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Perspectives and diagnostic considerations in spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Spinal muscular atrophy: mechanisms and therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Brief report: phenotypic rescue of induced pluripotent stem cell-derived motoneurons of a spinal muscular atrophy patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Induced pluripotent stem cells from a spinal muscular atrophy patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Friedreich's ataxia induced pluripotent stem cells model intergenerational GAA⋅TTC triplet repeat instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Generation of induced pluripotent stem cell lines from Friedreich ataxia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

X-linked adrenoleukodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Lovastatin and sodium phenylacetate normalize the levels of very long chain fatty acids in skin fibroblasts of X- adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

A human Dravet syndrome model from patient induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Dravet syndrome patient-derived neurons suggest a novel epilepsy mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Modeling Dravet syndrome using induced pluripotent stem cells (iPSCs) and directly converted neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Severe epilepsy syndromes of early childhood: the link between genetics and pathophysiology with a focus on SCN1A mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Persistent Sodium Current and Its Role in Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Generation of human induced pluripotent stem cells from dermal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

A high-efficiency system for the generation and study of human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Reprogramming of pancreatic beta cells into induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Generation of human induced pluripotent stem cells by simple transient transfection of plasmid DNA encoding reprogramming factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Generation of induced pluripotent stem cells using recombinant proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Reprogramming of mouse and human cells to pluripotency using mature microRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

Two Supporting Factors Greatly Improve the Efficiency of Human iPSC Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400010

21 January 2018

Identifiers

DOI

10.1002/BIOT.201400010

1 reference

31 August 2017

1 reference